Age & Research Use Notice

This website supplies research products intended strictly for in vitro laboratory and scientific research. Products are not for human or veterinary use, clinical use or self-administration.

You must be 18 or over to access this website.

Sorry, you must be 18 or over to access this site.

For in vitro laboratory research only. Not for human or veterinary use.

LIMITED-TIME SALE ON ALL PRODUCTS · FREE ROYAL MAIL TRACKED 24 OVER £25
Catalogue / KLOW

KLOW

Multi-compound research blend

80MG Third-party HPLC tested UK-based dispatch
KLOW 80mg vial
UK StockedReady to ship
Same-Day DispatchOrders placed before 2pm
Free Tracked 24On orders over £25

Compound overview

KLOW Blend is a multi-peptide research formulation combining four compounds used in experimental studies examining peptide signalling, extracellular matrix biology, endothelial pathways, inflammatory signalling, and multi-compound interactions.

Each vial contains an 80mg lyophilised blend comprising:

At a glance

Blend type Multi-compound research blend
Vial content 80MG
Components Pre-formulated
Format Lyophilised blend

Research focus

Multi-Peptide Interaction

Used in experimental systems examining how multiple peptide compounds may influence complementary or overlapping signalling pathways.

Extracellular Matrix Signalling

Investigated in models involving matrix-associated signalling, cellular organisation, and structural protein regulation.

Endothelial & Cellular Signalling

Studied in relation to endothelial activity, cellular migration, and associated signalling mechanisms.

Inflammatory Signalling

Examined in experimental models involving inflammatory mediators, cellular stress responses, and regulatory signalling pathways.

Key features

  • Third-party HPLC tested
  • 80mg total blend per vial
  • Contains GHK-Cu, BPC-157, TB-500, and KPV
  • Four-component formulation for multi-peptide research
  • Stable lyophilised format
  • UK stocked
View full research overview

KLOW Blend is a multi-peptide research formulation combining four compounds used in experimental studies examining peptide signalling, extracellular matrix biology, endothelial pathways, inflammatory signalling, and multi-compound interactions.

Each vial contains an 80mg lyophilised blend comprising:

  • GHK-Cu 50mg — copper-binding tripeptide
  • BPC-157 10mg — synthetic 15-amino-acid peptide
  • TB-500 10mg — thymosin beta-4-derived peptide
  • KPV 10mg — Lys-Pro-Val tripeptide

The formulation is intended for controlled in vitro laboratory research where multiple peptide compounds are investigated within the same experimental system, including studies of complementary, overlapping, or interacting biochemical pathways.

Key Features

  • Third-party HPLC tested
  • 80mg total blend per vial
  • Contains GHK-Cu, BPC-157, TB-500, and KPV
  • Four-component formulation for multi-peptide research
  • Stable lyophilised format
  • UK stocked

Area of Interest

Laboratory research involving the components of KLOW Blend has examined a number of interconnected biochemical and cellular pathways:

  • Multi-Peptide Interaction: Used in experimental systems examining how multiple peptide compounds may influence complementary or overlapping signalling pathways.
  • Extracellular Matrix Signalling: Investigated in models involving matrix-associated signalling, cellular organisation, and structural protein regulation.
  • Endothelial & Cellular Signalling: Studied in relation to endothelial activity, cellular migration, and associated signalling mechanisms.
  • Inflammatory Signalling: Examined in experimental models involving inflammatory mediators, cellular stress responses, and regulatory signalling pathways.
  • Copper-Peptide Biology: GHK-Cu is studied in relation to copper binding, peptide-mediated signalling, and cellular biochemical processes.

Together, these areas make KLOW Blend a multi-component formulation of interest for in vitro research into peptide interactions, cellular signalling, extracellular matrix biology, endothelial pathways, and inflammatory mechanisms.

For in vitro laboratory research only. Not for human or veterinary use.

ProductKLOW 80mg Blend
CompositionGHK-Cu 50 mg + BPC-157 10 mg + TB-500 10 mg + KPV 10 mg (Total 80 mg)
FormLyophilized powder
Purity (each peptide)≥98% (HPLC verified)
AppearanceBlue-tinged lyophilized cake
Storage (lyophilized)Refrigerate at 2–8°C; for long-term storage, freeze at −20°C.

Lyophilized Storage

Store refrigerated at 2–8°C. For long-term storage, store frozen at −20°C. Keep sealed and protected from light and moisture.

⚠ For in vitro laboratory research only. Not for human or veterinary use.
KLOW
80MG

4-peptide blend

GHK-Cu 50mg · BPC-157 10mg · TB-500 10mg · KPV 10mg

Limited-time price
Original price was: £89.95.Current price is: £64.95.-28%
Calculating dispatch time...
In Stock · UK dispatch

For in vitro laboratory research only. Not for human or veterinary use.

Third-party tested Free Tracked 24 over £25 Secure checkout
Visa, Mastercard, Apple Pay, Google Pay, Amazon Pay and Pay by Bank
JOIN THE RESEARCH LIST

Batch alerts. New compounds. Research updates.